Hiperfiltración glomerular en el paciente traumático grave / Glomerular hyperfiltration in patients with severe trauma

Antecedentes y objetivo El aclaramiento renal aumentado o hiperfiltración glomerular (HFG) puede afectar significativamente a los resultados clínicos de los fármacos eliminados por vía renal al promover la exposición subterapéutica al fármaco. La agresión sufrida en los pacientes que presentan trauma grave supone un predisponente a manifestar HFG y la identificación de estos pacientes sigue siendo un desafío clínico. El objetivo principal de este estudio fue describir la prevalencia de HFG en una cohorte de pacientes críticos traumatizados en la primera semana de ingreso. Materiales y métodos Estudio prospectivo observacional de una cohorte de pacientes adultos ingresados en la UCI de Anestesiología del Complejo Hospitalario Universitario de Albacete (España) tras sufrir un trauma grave o politraumatismo. Se calculó el aclaramiento de creatinina (ClCr) en muestra de recolección de orina 4h a las 24, 72 y 168h de ingreso aplicando la fórmula ClCr: [Diuresis en ml (orina/4h)×Creatinina en orina (mg/dl)]÷[240 (minutos)×Creatinina en plasma (mg/dl)]. Un CrCl por encima de 130ml/min fue considerado HFG. Los análisis se realizaron con el software estadístico R versión 4.0.4. Resultados Se incluyeron 85 pacientes. La edad mediana de los pacientes fue de 51 años (RIQ 26); 68 pacientes fueron varones (78,82%). El 75,29% de los pacientes fueron politraumatizados; 61 pacientes (71,76%) presentaron HFG en algún momento de la determinación del ClCr. A las 24h de ingreso el 56,34% de los pacientes presentaron HFG con ClCr medio de 195,8ml/min, el 61,11% de los pacientes lo presentaban a las 72h con ClCr medio de 186ml/min y el 56,52% presentaban HFG a las 168h de ingreso con ClCr medio de 207ml/min. Se encontró una relación positiva importante (p=0,07) entre la HFG manifestada a las 72h y a las 168h. Se observó relación estadísticamente significativa entre este fenómeno con edades más jóvenes, puntuaciones ISS más bajas y creatininas plasmáticas más bajas (AU)

Background and objective Augmented renal clearance or glomerular hyperfiltration (GHF) can significantly affect the clinical outcomes of renally eliminated drugs by promoting subtherapeutic drug exposure. The aggression suffered in patients who suffer severe trauma is a predisposition to manifest GHF and the identification of these patients remains a clinical challenge. The main objective of this study was to describe the prevalence of GHF in a cohort of critically ill trauma patients. Materials and methods Prospective observational study of a cohort of adult patients admitted after suffering severe trauma or polytrauma in the Anesthesiology ICU of the University Hospital of Albacete (Spain). Creatinine clearance (ClCr) was calculated in a 4-h urine collection sample at 24, 72 and 168h after admission applying the formula: CrCl: [diuresis in ml (urine/4h)×creatinine in urine (mg/dl)]÷[240 (min)×creatinine in plasma (mg/dl)]. A CrCl above 130ml/min was considered GHF. The analyzes were performed with the statistical software R version 4.0.4. Results Eighty-five patients were included. The median age of the patients was 51 years (IQR 26). Sixty-eight patients were male (78.82%). 75.29% of the patients were polytraumatized. Sixty-one patients (71.76%) presented GHF at some point in the CrCl determination. At 24h of admission, 56.34% of the patients presented GHF with a mean CrCl of 195.8ml/min, 61.11% of the patients presented it at 72h with a mean CrCl of 186ml/min and 56.52% presented GHF at 168h of admission with a mean CrCl of 207ml/min. A significant positive relationship (p=0.07) was found between GHF manifested at 72h and at 168h. We observed a statistically significant relationship between this phenomenon with younger ages, lower ISS scores and lower plasma creatinines (AU)

Glomerular hyperfiltration in patients with severe trauma.

BACKGROUND AND OBJECTIVE: Augmented renal clearance or glomerular hyperfiltration (GHF) can significantly affect the clinical outcomes of renally eliminated drugs by promoting subtherapeutic drug exposure. The aggression suffered in patients who suffer severe trauma is a predisposition to manifest GHF and the identification of these patients remains a clinical challenge. The main objective of this study was to describe the prevalence of GHF in a cohort of critically ill trauma patients. MATERIALS AND METHODS: Prospective observational study of a cohort of adult patients admitted after suffering severe trauma or polytrauma in the Anesthesiology ICU of the University Hospital of Albacete (Spain). Creatinine clearance (ClCr) was calculated in a 4-h urine collection sample at 24, 72 and 168 h after admission applying the formula; CrCl: [Diuresis in ml (urine/4 h) × Creatinine in urine (mg/dl)] ÷ [240 (minutes) × Creatinine in plasma (mg/dl)]. A CrCl above 130 mL/min was considered GHF. The analyses were performed with the statistical software R version 4.0.4. RESULTS: 85 patients were included. The median age of the patients was 51 years (IQR 26), 78.82% male. 68 patients were male (78.82%). 75.29% of the patients were polytraumatized. 61 patients (71.76%) presented GHF at some point in the CrCl determination. At 24 h of admission, 56.34% of the patients presented GHF with a mean CrCl of 195.8 ml/min, 61.11% of the patients presented it at 72 h with a mean CrCl of /min and 56.52% presented GHF at 168 h of admission with a mean CrCl of 207 ml/min. A significant positive relationship (p = 0.07) was found between GHF manifested at 72 h and at 168 h. We observed a statistically significant relationship between this phenomenon with younger ages, lower ISS scores and lower plasma creatinines. CONCLUSIONS: GHF are a common condition in critically ill patients admitted for severe trauma. We recommend the use of CrCl to assess renal function and make dosage adjustments. Studies are required to understand the clinical impact of these phenomena on drug elimination and to be able to establish the ideal dosage in those cases.

Hemorragias intracraneales en pacientes críticos COVID-19: reporte de tres casos / Intracranial hemorrhages in critical COVID-19 patients: report of three cases

No disponible